Stockscreener 앱 받기
65.23
0.80%
0.5518
Alcon Inc 주식(ALC)의 최신 뉴스
The Systane Ultra Lubricant Eye Drops from Alcon Inc.everyday dry-eye relief in compact vials - AD HOC NEWS
Alcon refines long-term strategy, shares supported by clear analyst consensus - AD HOC NEWS
Quiet comfort in the eyewhy Alcon’s PRECISION1 daily lenses feel almost invisible - AD HOC NEWS
Alcon StockWeekly review and sector comparison - AD HOC NEWS
Soft start into silicone hydrogel, Alcon’s PRECISION1 daily lens aims for easy wearers - AD HOC NEWS
Why Alcon’s SYSTANE Hydration PF has become a quiet everyday essential - AD HOC NEWS
Alcon AG (ALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
New contact lens comfort data puts Alcon’s DAILIES TOTAL1 center stage - AD HOC NEWS
Alcon launches Unity CS cataract surgery system in Canada - Investing.com UK
New treatment option for cataract surgeons, Alcon Clareon IOL expands premium lineup - AD HOC NEWS
Canadian launch sets the stage for Alcon’s UNITY CS cataract system - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Eye-care leader in focus after recent trading and sector moves - AD HOC NEWS
Alcon launches Unity CS cataract surgery system in Canada By Investing.com - Investing.com South Africa
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada - Eagle-Tribune
Alcon Inc. (ALC) Stock Analysis: Eyeing A 31.52% Potential Upside In The Healthcare Market - DirectorsTalk Interviews
Alcon Inc. Stock (CH0432492467): Ownership changes put the eye-care group in focus - AD HOC NEWS
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Alcon Inc. Stock (CH0432492467): Valuation metrics keep eye-care leader in focus - AD HOC NEWS
Alcon Inc Stock (CH0432492467): Citi reiterates Buy rating and sees upside potential - AD HOC NEWS
Alcon DAILIES TOTAL1 contact lenses: daily comfort for dry-eye wearers - AD HOC NEWS
KeyBanc Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $88 - Moomoo
Alcon (ALC) Gets a Buy from Citi - The Globe and Mail
Citi Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $103 - Moomoo
Alcon Inc Stock (CH0432492467): Analyst targets highlight upside after Q1 update - AD HOC NEWS
Systane class action claims eye drops falsely advertised as preservative-free - Class Action Lawsuits
Alcon Inc. stock (CH0432492467): eye-care specialist steadies after Q1 2026 update - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist steadies after Q1 earnings and dividend update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after recent earnings and outlook - AD HOC NEWS
Alcon Inc. stock (CH0432492467): eye-care specialist edges higher after Q1 earnings and guidance upd - AD HOC NEWS
Alcon Inc. stock (CH0432492467): Eye-care specialist builds on Q1 earnings momentum - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after recent earnings update - AD HOC NEWS
BTIG lowers Alcon stock price target to $82 on lower valuation - Investing.com
Alcon faces class-action lawsuit over false product marketing - Eyes On Eyecare
Alcon shares see BofA reiterate underperform on soft Q1 results - Investing.com
Alcon Q1 2026 slides: EPS beats but revenue miss sparks selloff - Investing.com
Alcon Inc stock (CH0432492467): shares steady after Q1 2026 earnings beat and raised guidance - AD HOC NEWS
Swiss eye care firm Alcon's quarterly revenue rises less than expected - marketscreener.com
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued - GuruFocus
Alcon Inc stock (CH0432492467): sector backdrop in focus as shares consolidate - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares hover in mid-60 USD range on NYSE as investors await next ea - AD HOC NEWS
Alcon Inc. stock (CH0432492467): shares near mid-60 USD range ahead of next earnings update - AD HOC NEWS
Recalled Systane, GenTeal Tears Eye Products Falsely Labeled as ‘Sterile’ Despite Contamination Risks, Class Action Claims - ClassAction.org
Alcon Inc. (ALC) Stock Analysis: Eyeing a 33.54% Potential Upside in the Growing Healthcare Sector - DirectorsTalk Interviews
Alcon Inc stock (CH0432492467): Shares steady as investors digest Q1 2026 results and eye care marke - AD HOC NEWS
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy) (NYSE:ALC) - Seeking Alpha
Alcon Inc. stock (CH0432492467): shares steady as Swiss eye-care group trades near recent highs - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group holds near USD mid-60s as investors track valuation m - AD HOC NEWS
Alcon Inc. stock (CH0432492467): steady trading ahead of next catalysts and valuation focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Swiss-listed shares slip in line with market - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care group steady as investors watch sector trends - AD HOC NEWS
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - TradingView
Alcon stock: Earnings, guidance and lens demand in focus - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings and guidance upda - AD HOC NEWS
Alcon Inc stock (CH0432492467): eye-care specialist in focus after latest earnings - AD HOC NEWS
Alcon Inc stock (CH0432492467): Eye-care specialist in focus after latest earnings update - AD HOC NEWS
Alcon Inc stock (CH0432492467): Q1 2026 earnings beat keeps eye-care specialist in focus - AD HOC NEWS
Southpoint Capital Advisors LP's Alcon Inc(ALC) Holding History - GuruFocus
Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap - Yahoo Finance
1.24%
0.25%
자본화:
|
볼륨(24시간):